BioScience Health Innovations (BHIC) Shares Outstanding (Diluted Average) (2023 - 2026)

BioScience Health Innovations (BHIC) has 4 years of Shares Outstanding (Diluted Average) data on file, last reported at $11.4 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $11.4 million, down 74.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.4 million (down 74.34% YoY), and the FY2025 annual result was $11.4 million, up 4.54% from the prior year.
• Shares Outstanding (Diluted Average) held at $11.4 million in Q1 2026 per BHIC's latest filing, from $11.4 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $44.3 million in Q1 2025 and troughed at $10.9 million in Q3 2024.
• A 4-year average of $26.6 million and a median of $31.4 million in 2023 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Diluted Average) increased 7.11% in 2025, then plunged 74.34% in 2026.
• A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $33.8 million in 2023, then tumbled by 67.71% to $10.9 million in 2024, then advanced by 4.54% to $11.4 million in 2025, then retreated by 0.2% to $11.4 million in 2026.
• Business Quant data shows BHIC's Shares Outstanding (Diluted Average) at $11.4 million in Q1 2026, $11.4 million in Q4 2025, and $11.4 million in Q3 2025.